GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / BioBasic / Actinomycin D / Product Detail : ADJ719 Actinomycin D
Related keywords:
May
27th
#ADJ719 Actinomycin D
| Price : | 126 | EUR |
| 143 | USD | |
| 97 | GBP | |
| 530 | Zloty | |
| 16890 | JPY | |
| 973 | NOK | |
| 1043 | SEK | |
| 142 | CHF |
Product name : Actinomycin D
Catalog number : ADJ719
Quantity: 5MG
Availability: Yes
Supplier name : BioBasic
Data sheet: Ask more or other datasheet now !
Contact us about this product :
Our team will respond you as soon as possible !
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Related products : Actinomycin D
Gentaurpub
No related Items
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[MDM2] E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)
[Mdm2] E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)
[TP53 P53] Cellular tumor antigen p53 (Tumor suppressor p53)
[TP53] Cellular tumor antigen p53 (Tumor suppressor p53)
[DHX9 DDX9 LKP NDH2] ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II)
[TP53 P53] Cellular tumor antigen p53 (Tumor suppressor p53)
[KAT7 HBO1 HBOa MYST2] Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)
[TP53 TRP53] Cellular tumor antigen p53 (Tumor suppressor p53)
[H2AFX H2AX] Histone H2AX (H2a/x) (Histone H2A.X)
[TP53] Cellular tumor antigen p53 (Tumor suppressor p53)
[Mdm2] MDM2 proto-oncogene
[RPL23] 60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14)
[Trp53 p53 mCG_20908] Cellular tumor antigen p53
[NOC2L NIR] Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)
[TP53] Cellular tumor antigen p53
[LOC100910954] Cellular tumor antigen p53
[EEF1E1 AIMP3 P18] Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18)
[Gfer Alr] FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration)
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
[TP53] Cellular tumor antigen p53
Bibliography :
[28548706] 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
[28539972] Site-specific regulation of histone H1 phosphorylation in pluripotent cell differentiation.
[28516114] Measurement of mRNA Decay in Mouse Embryonic Fibroblasts.
[28510139] Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein.
[28503314] Atypical teratoid/rhabdoid tumor of lumbar spine in a toddler child.
[28497562] Different aggregation states of a nuclear localization signal-tagged 25-kDa C-terminal fragment of TAR RNA/DNA-binding protein 43 kDa.
[28495269] Identification of novel regulatory GRE-binding elements in the porcine IP3R1 gene promoter and their transcriptional activation under glucocorticoid stimulation.
[28494471] Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
[28482026] Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
[28467408] Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.
Share this page:
Enter catalog number :
Favorites Pages:
No Favorits